Alphabet Inc., 10% Owner at Prime Medicine, Inc. (PRME), sold 395,583 shares at $14.13 ($3.8M) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Scheduled sale ($3.8M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 87,922 | $0 | 0.0% |
| 2 | $14.13 | 87,922 | $1.2M | 32.9% |
| 3 | $14.13 | 87,922 | $1.2M | 32.9% |
| 4 | $0.00 | 43,939 | $0 | 0.0% |
| 5 | $14.74 | 43,939 | $648K | 17.1% |
| 6 | $14.74 | 43,939 |
| $648K |
| 17.1% |
| Total | $9.56 avg | 395,583 | $3.8M | 100% |
| Filing → |
| PRME | SELL | 2023-06-20 | $2.2M | — | Filing → |
| PRME | SELL | 2023-05-26 | $728K | — | Filing → |
| GTLB | BUY | 2023-05-09 | $393K | — | Filing → |